GlobalData forecasts AbbVie holding strong in immunology - The Pharma Letter

GlobalData forecasts AbbVie holding strong in immunology  The Pharma Letter

A report from industry analyst GlobalData suggests that AbbVie's (NYSE: ABBV) strong immunology pipeline will protect its grip on the plaque psoriasis and ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases